ANALYSIS OF HEMATOLOGICAL CHANGES IN TOFACITINIB-TREATED PATIENTS WITH ULCERATIVE COLITIS ACROSS PHASE 3 INDUCTION AND MAINTENANCE STUDIES

被引：0
|
作者：
Lichtenstein, Gary R.
Moore, Gregory T.
Soonasra, Arif
Nduaka, Chudy I.
Kwok, Kenneth
Wang, Lisy
Lawendy, Nervin
Chan, Gary
Su, Chinyu
Loftus, Edward V.
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1752
引用
收藏
页码：S1111 / S1111
页数：1
相关论文
共 50 条
  • [31] Onset of Efficacy of Tofacitinib for Induction Therapy in Patients with Active Ulcerative Colitis in Two Multinational, Phase 3 Clinical Trials
    Sandborn, William J.
    Danese, Silvio
    Panes, Julian
    Zhang, Haiying
    Woodworth, Deborah
    Marren, Amy
    Su, Chinyu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S260 - S260
  • [32] ONSET OF EFFICACY OF TOFACITINIB FOR INDUCTION THERAPY IN PATIENTS WITH ACTIVE ULCERATIVE COLITIS IN TWO MULTINATIONAL, PHASE 3 CLINICAL TRIALS
    Danese, S.
    Sandborn, W. J.
    Panes, J.
    Zhang, H.
    Woodworth, D.
    Marren, A.
    Su, C.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 : E90 - E91
  • [33] Efficacy of Tofacitinib in Patients With Ulcerative Colitis by Prior Tumor Necrosis Factor Inhibitor Treatment Status: Results From OCTAVE Induction and Maintenance Studies
    Dubinsky, Marla C.
    Peyrin-Biroulet, Laurent
    Melmed, Gil Y.
    Hou, Jason K.
    Woodworth, Deborah A.
    Friedman, Gary S.
    Zhang, Haiying
    Maller, Eric
    Quirk, Daniel
    Nduaka, Chudy I.
    Su, Chinyu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S354 - S354
  • [34] Ustekinumab Improved Work Productivity in Patients With Moderate to Severe Ulcerative Colitis: Results From the Phase 3 UNIFI Induction and Maintenance Studies
    Han, Chenglong
    Naessens, Dominik
    Zhang, Hongyan
    Johanns, Jewel
    Marano, Colleen
    Sands, Bruce E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S438 - S438
  • [35] Efficacy and safety of ustekinumab in East Asian patients with moderately to severely active ulcerative colitis: a subpopulation analysis of global phase 3 induction and maintenance studies (UNIFI)
    Hisamatsu, Tadakazu
    Kim, Hyo Jong
    Motoya, Satoshi
    Suzuki, Yasuo
    Ohnishi, Yoshifumi
    Fujii, Noriyuki
    Matsushima, Nobuko
    Zheng, Richuan
    Marano, Colleen W.
    INTESTINAL RESEARCH, 2021, 19 (04) : 386 - +
  • [36] A PHASE 3 STUDY OF VEDOLIZUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN JAPANESE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Watanabe, Mamoru
    Motoya, Satoshi
    Watanabe, Kenji
    Ogata, Haruhiko
    Kanai, Takanori
    Matsui, Toshiyuki
    Suzuki, Yasuo
    Shikamura, Mitsuhiro
    Igeta, Masataka
    Oda, Kazunori
    Hori, Tetsuharu
    Araki, Takahiro
    Hibi, Toshifumi
    GASTROENTEROLOGY, 2018, 154 (06) : S380 - S381
  • [37] Tofacitinib for Maintenance Therapy in Patients With Active Ulcerative Colitis in the Phase 3 OCTAVE Sustain Trial: Results by Local and Central Endoscopic Assessments
    Feagan, Brian G.
    Vermeire, Severine
    Sandborn, William J.
    Reinisch, Walter
    Panes, Julian
    Tarabar, Dino
    Su, Chinyu
    Niezychowski, Wojciech
    Zhang, Haiying
    Friedman, Gary S.
    Woodworth, Deborah A.
    Sands, Bruce E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S329 - S329
  • [38] GENERAL HEALTH STATUS IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS RECEIVING USTEKINUMAB: RESULTS FROM THE PHASE 3 UNIFI INDUCTION AND MAINTENANCE STUDIES
    Danese, Silvio
    Sands, Bruce E.
    Leong, Rupert W.
    Zhang, Hongyan
    Johanns, Jewel
    Szapary, Philippe
    Marano, Colleen W.
    Han, Chenglong
    GASTROENTEROLOGY, 2019, 156 (06) : S442 - S442
  • [39] General health status in patients with moderate to severe ulcerative colitis receiving ustekinumab: results from the Phase 3 UNIFI induction and maintenance studies
    Danese, S.
    Sands, B. E.
    Leong, R. W.
    Zhang, H.
    Johanns, J.
    Szapary, P.
    Marano, C.
    Han, C.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S311 - S312
  • [40] EFFICACY OF TOFACITINIB MAINTENANCE THERAPY FOR ULCERATIVE COLITIS IN REMITTING PATIENTS VS PATIENTS WITH CLINICAL RESPONSE AFTER 8 WEEKS OF INDUCTION TREATMENT
    Reinisch, Walter
    Osterman, Mark T.
    Doherty, Glen
    Marren, Amy
    Woodworth, Deborah A.
    Lawendy, Nervin
    Kwok, Kenneth
    Maller, Eric S.
    Su, Chinyu
    GASTROENTEROLOGY, 2019, 156 (06) : S1098 - S1098
12345